Stephens & Co. Reiterates Equal-Weight on Humana, Maintains $250 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel has reiterated an Equal-Weight rating on Humana (NYSE:HUM) and maintained a price target of $250.
October 09, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stephens & Co. has reiterated its Equal-Weight rating on Humana, maintaining a price target of $250. This suggests a neutral stance on the stock's short-term performance.
The reiteration of an Equal-Weight rating and maintenance of the $250 price target by Stephens & Co. indicates a neutral outlook on Humana's stock. This suggests that the analyst does not foresee significant short-term price movement, either upward or downward.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100